GoodRx Holdings rises on upbeat prelim Q4 2023 revenue

GoodRx Holdings

10/01/2024 15:10

** Digital healthcare platform GoodRx Holdings'  GDRX.O 
shares rise 11.5% to $6.40
    ** Company reports upbeat prelim Q4 and prelim FY 2023
revenue, higher than GDRX's forecast issued in November
    ** GDRX expects revenue and adjusted revenue for Q1 2024 and
FY 2024 will grow in mid-single digit percentages y-o-y
    ** Company expects Q4 revenue between $195 mln and $197 mln,
vs est $190.8 mln - LSEG
    ** GoodRx forecasts FY 2023 revenue between $759 mln and
$761 mln, vs est $744.3 mln
    ** Company's shares rose about 44% in 2023

 (Reporting by Pranav Kashyap and Pratik Jain in Bengaluru)
 ((Pranav.Kashyap@thomsonreuters.com))